The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Clinical significance of germline CFTR mutations in pancreatic cancer.
 
Nicholas Liguori
No Relationships to Disclose
 
Matthew Ebia
No Relationships to Disclose
 
Maya Yates
No Relationships to Disclose
 
Suzanne Dotson
No Relationships to Disclose
 
Anser Abbas
No Relationships to Disclose
 
Keon Khosravi
No Relationships to Disclose
 
Nanor Haladjian
No Relationships to Disclose
 
Eduardo Canto
No Relationships to Disclose
 
Stephen Pandol
No Relationships to Disclose
 
Anjaparavanda Naren
No Relationships to Disclose
 
Brent Larson
No Relationships to Disclose
 
Jun Gong
Honoraria - Agenus; Amgen; Astellas Pharma; AVEO; Basilea Pharmaceutical; Bayer; BeiGene; Clinical Congress Consultants; Eisai; Elsevier; EMD Serono; Exelixis; HalioDx; Incyte; Janssen Biotech; Natera; Pfizer; Pfizer/Myovant; QED Therapeutics; Seagen; Taiho Pharmaceutical
Consulting or Advisory Role - Agenus; Amgen; Astellas Pharma; AVEO; Basilea; Bayer; BeiGene; Caper Labs; Clinical Congress Consultants; Eisai; Elsevier; EMD Serono/Merck; Exelixis; HalioDx; Incyte; Janssen Biotech; MJH Life Sciences; Natera; OncLive/MJH Life Sciences; Pfizer; Pfizer/Myovant; QED Therapeutics; Seagen; Taiho Pharmaceutical
Patents, Royalties, Other Intellectual Property - PCT/US2021/043961 provisional patent on glutamine and cancer; U.S. Provisional Application Serial No. 63/315,895 on methylated ctDNA markers
 
Andrew Hendifar
Consulting or Advisory Role - Amgen; Exelixis; Exelixis; Exelixis; Faraday Pharmaceuticals; Ipsen; Merus; Novartis; Pancreatic Cancer Action Network; Regeneron; Valar Labs; Varian Medical Systems
Research Funding - Ipsen; NGM Biopharmaceuticals (Inst)
Travel, Accommodations, Expenses - Halozyme
Other Relationship - Rayzebio
 
Arsen Osipov
No Relationships to Disclose